Logo

American Heart Association

  137
  0


Final ID:

Panel Discussion

  • Wiviott, Stephen  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Stephen Wiviott: DO have relevant financial relationships ; Researcher:AstraZeneca:Active (exists now) ; Consultant:ICON:Active (exists now) ; Consultant:NovoNordisk:Active (exists now) ; Researcher:Merck:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

More abstracts on this topic:
TRISCEND II 1-Year Outcomes (primary results at TCT)

Hahn Rebecca, Thourani Vinod, Kodali Susheel

EARLY-TAVR (primary results at TCT)

Genereux Philippe, Leon Martin

More abstracts from these authors:
Polygenic Risk Score Associated With Kidney Disease Progression In Patients With Cardiometabolic Risk Factors

Park Jun, Marston Nicholas, Kamanu Frederick, Melloni Giorgio, Lai Yi-pin, Giugliano Robert, Scirica Benjamin, Wiviott Stephen, Sabatine Marc, Ruff Christian

SGLT2 inhibitors: the new antiarrhythmic around the block?

Patel Siddharth, Wiviott Stephen

You have to be authorized to contact abstract author. Please, Login
Not Available